AstraZeneca is partnering with Oracle to bring AI into clinical research. The angle for the tape is pharma R&D productivity and Oracle's healthcare AI footprint. Another enterprise AI deal to watch. $

What happened: AstraZeneca is partnering with Oracle to refine clinical research using artificial intelligence, the latest AI partnership in the pharmaceutical industry. Why it matters: The deal adds to a growing set of AI partnerships in pharma, as drugmakers look to apply the technology to clinical research.

AstraZeneca-Oracle AI partnership targets clinical research efficiency, a concrete catalyst.

AstraZeneca-Oracle AI partnership targets clinical research efficiency, a concrete catalyst. — impact context not separately stored; see What changed.